Publications

Influential drivers of the cost-effectiveness of respiratory syncytial virus vaccination in European older adults: A multi-country analysis.

Li, X; Willem, L; Johannesen, CK; Urchueguía-Fornes, A; Lehtonen, T; Osei-Yeboah, R; Salo, H; Orrico-Sánchez, A; Díez-Domingo, J; JIT, M; Bilcke, J; Nair, H; Beutels, P;

2024

Cold Spring Harbor Laboratory (2024). 10.1101/2024.08.06.24311440.

Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study.

Lin, L-Y; Henderson, AD; CARLILE, O; Dillingham, I; Butler-Cole, BF C; MARKS, M; BRIGGS, A; JIT, M; TOMLINSON, LA; Bates, C; Parry, J; Bacon, SC J; GOLDACRE, B; Mehrkar, A; MacKenna, B; OpenSAFELY Collaborative,; EGGO, RM; HERRETT, E;

2024

BMC medicine, (2024).22 1 10.1186/s12916-024-03477-x.

enilles1/immunoepidemiology.

Nilles, EJ; KUCHARSKI, AJ;

2024

, Github (2024).

What is next for BCG revaccination to prevent tuberculosis?.

WHITE, RG; Fiore-Gartland, AJ; Hanekom, WA; Vekemans, J; Garcia-Basteiro, AL; Churchyard, G; Rangaka, MX; Frick, M; Behr, MA; Hill, PC; Mave, V;

2024

The Lancet Respiratory medicine, (2024).12 3 10.1016/S2213-2600(24)00009-2.

Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report.

CLARK, RA; Young, C; Palmer, S; Auma, E; Malhotra, S; Limaye, R; Giersing, B; Schrager, L; Voss, G; Tiemersma, E; Frick, M; Edoka, I; Dagnew, AF; Nkhoma, T; Pelzer, PT; WHITE, RG;

2024

Frontiers in Tuberculosis, (2024).2, 10.3389/ftubr.2024.1384036.

Factors Associated with Usage of Oral-PrEP among Female Sex Workers in Nairobi, Kenya, Assessed by Self-Report and a Point-of-Care Urine Tenofovir Immunoassay.

Shah, P; Spinelli, M; Irungu, E; Kabuti, R; Ngurukiri, P; Babu, H; Kungu, M; Champions, TM F S; Nyabuto, C; Mahero, A; DEVRIES, K; KYEGOMBE, N; MEDLEY, GF; GAFOS, M; SEELEY, J; WEISS, HA; Kaul, R; Gandhi, M; BEATTIE, TS; Kimani, J;

2024

AIDS and behavior, (2024).28 11 10.1007/s10461-024-04455-3.

A health technology assessment of COVID-19 vaccination for Nigerian decision-makers: Identifying stakeholders and pathways to support evidence uptake.

Uzochukwu, BS C; Okeke, C; Shuaib, F; Torres-Rueda, S; VASSALL, A; JIT, M; Nonvignon, J; Uzochukwu, AC; RUIZ, F;

2024

Health research policy and systems, (2024).22 1 10.1186/s12961-024-01158-y.

Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study.

Krauer, F; Guenther, F; Treskova-Schwarzbach, M; Schoenfeld, V; Koltai, M; Jit, M; HODGSON, D; Schneider, U; Wichmann, O; Harder, T; Sandmann, FG; FLASCHE, S;

2024

BMC medicine, (2024).22 1 10.1186/s12916-024-03687-3.

Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria.

Williams, SV; Akande, T; ABBAS, K;

2024

PLoS One, (2024).19 3 10.1371/journal.pone.0297326.

Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study.

CLARK, RA; Portnoy, A; Weerasuriya, CK; SUMNER, T; Bakker, R; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;

2024

The Lancet regional health - Southeast Asia (2024). 10.1016/j.lansea.2024.100424.